Mokkapati v. Mayorkas

District Court, District of Columbia·Decided July 19, 2022·No. Civil Action No. 2021-1195·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

ADITYA MOKKAPATI, et al., Plaintiffs,

v. Civil Action No. 21-cv-1195 (BAH)

ALEJANDRO MAYORKAS, Chief Judge Beryl A. Howell in his official capacity as Secretary of the Department of Homeland Security, et al.,

Defendants.

MEMORANDUM OPINION

Plaintiffs Aditya Mokkapati and Chaitanya Prasad Gullapalli, both citizens of India living in the United States on H-1B and F-1 visas, respectively, seek to compel defendants—senior officials at the U.S. Department of Homeland Security and the U.S. Citizenship and Immigration Services (“USCIS”)—to adjudicate their Form I-526 petitions that have been pending without decision for over two years. Compl. ¶¶ 23-24, 55, ECF No. 1. Plaintiffs assert that the “continued delay in the adjudication” of their petitions, which if granted may allow them to become lawful permanent residents of the United States, “has caused inordinate and unfair amounts of stress, expense, and hassle” and thus entitles them to relief under the Administrative Procedure Act (“APA”), 5 U.S.C. §§ 555(b), 706(1) et seq., and the Mandamus Act, 28 U.S.C. § 1361. Compl. ¶¶ 7, 35-36. During the pendency of plaintiffs’ petitions, statutory authorization for the EB-5 visa program through which plaintiffs seek permanent residence in this country lapsed in June 2021 and was recently renewed by Congress in March 2022. See id. ¶ 52; Defs.’

Notice of Withdrawal of Mot. Dismiss in Part (“Defs.’ Notice”) at 1, ECF No. 18. 1 Defendants now move to dismiss the complaint, under Federal Rule of Civil Procedure 12(b)(6), for failure to state a plausible claim that any alleged delay is “unreasonable as a matter of law.” Defs.’ Mot. Dismiss and Mem. Supp. (“Defs.’ Mem.”) at 13, ECF No. 13. As further explained below, defendants’ motion to dismiss is granted.

I. BACKGROUND Summarized below are brief reviews of the statutory, regulatory, and factual background underlying the claims followed by the procedural history of this case.

A. Statutory and Regulatory Background The Immigration and Nationality Act (“INA”), 8 U.S.C. § 1101 et seq., authorizes the issuance of visas to different categories of immigrants, including a fifth preference category (“EB-5”) visa issued to immigrants who contribute to “employment creation” by investing in new commercial enterprises that create full-time jobs for American workers. Immigration Act of 1990, Pub. L. No. 101-649, § 121(a), 104 Stat. 4978, 4989 (Nov. 29, 1990) (codified at 8 U.S.C. § 1153(b)(5)); see 8 C.F.R. § 204.6 (2020) (defining the requirements and process for EB-5 “alien entrepreneur” classification). An I-526 petition is “the mechanism by which individuals who are eligible to immigrate to the United States through the [EB-5 category] obtain recognition from the government that they have satisfied the investment and job-creation requirements of that visa-preference category.” Bromfman v. U.S. Citizenship and Immigr. Servs., No. 20-cv-571 (BAH), WL 5014436, at *1 (D.D.C. Oct. 28, 2021).

To qualify for a visa under the EB-5 category, an immigrant must first file an I-526 petition with USCIS and “create full-time employment for not fewer than 10 United States

1 All references to the parties’ briefs and associated exhibits reflect the enumeration generated automatically by the Court’s Case Management/Electronic Case Filing (“CM/ECF”) system.

citizens or aliens lawfully admitted for permanent residency or other immigrants lawfully authorized to be employed in the United States (other than the immigrant and the immigrant's spouse, sons, or daughters).” 8 U.S.C. § 1153(b)(5)(A)(ii). In furtherance of that jobs-creation objective, the immigrant must have made or be in the process of making an investment of at least $1,000,000 generally or at least $500,000 into a “targeted employment area.” Id. § 1153(b)(5)(C)(ii). USCIS permits certain so-called “economic units” to apply for categorization as a “targeted employment area” and designation as a “regional center” through the Immigrant Investor Pilot Program, also called the Regional Center Program. See Departments of Commerce, Justice, and State, the Judiciary and Related Agencies Appropriations Act of 1993 (“Appropriations Act”), Pub. L. No. 102-395, § 610(a), 106 Stat. 1828, 1874 (Oct. 6, 1992); 8 C.F.R. § 204.6(m).

Successful adjudication and approval of an I-526 petition confers eligibility for, but does not automatically provide, a visa to a petitioner. “Once the [I-526] petition is processed and [if] a visa becomes available—which may take years—the immigrant advances to ‘conditional’ lawful permanent resident status.” Mirror Lake Vill., LLC v. Wolf, 971 F.3d 373, 375 (D.C. Cir. 2020) (citing 8 C.F.R. § 216.6(a)(4)(iii)-(iv)). This approved eligibility status permits foreign investors (and their dependent family members) to apply for two-year conditional permanent resident status either from within the United States or overseas from the State Department at the United States consular post in the petitioner’s home country. See 8 U.S.C. §§ 1186b(a)(1), 1201(a), 1255(i); 8 C.F.R. § 245.2; 22 C.F.R. §§ 42.32(e), 42.41, 42.42.

Although Congress had consistently reauthorized the Regional Center Program since its establishment in 1992, Bromfman, WL 5014436, at *2, this authorization expired on June 30, 2021, see Appropriations Act, as amended by, Consolidated Appropriations Act of 2021, Pub. L.

No. 116-260, Div. O, § 104, 134 Stat 1182, 2148 (2020). Upon the program’s statutory sunset, USCIS announced that it would “not act on any pending I-526 petition ‘that is dependent on the lapsed statutory authority and was filed before the end of the statutory authorization.’” Bromfman, WL 5014436, at *4 n.4 (citations omitted); id. at 4 (noting that, throughout lapse of program’s authorization, any actions taken by USCIS “to process plaintiff’s application would not advance plaintiff’s efforts to obtain a Regional Center visa—since Congress has not authorized any” (cleaned up)).

Almost nine months later, on March 15, 2022, President Biden signed the Consolidated Appropriations Act of 2022 into law, which included the EB-5 Reform and Integrity Act of 2022 reauthorizing the Regional Center Program. See Pub. L. No. 117-103, Div. BB, § 101, 136 Stat. 1070 (2022); Defs.’ Notice at 1. The relevant agencies, including USCIS, have over the last few months reimplemented the program and resumed the intake and processing of I-526 petitions. See EB-5 Reform and Integrity Act § 101; Defs.’ Notice at 1. During the period of lapsed authorization, USCIS held in abeyance petitions filed before July 1, 2021, including plaintiffs,’ Pls.’ Opp’n to Defs.’ Mot. Dismiss (“Pls.’ Opp’n”) at 11, ECF No. 14, and rejected any petitions filed after that date, see Bromfman, WL 5014436, at *4 n.4.

Free access — add to your briefcase to read the full text and ask questions with AI

Mokkapati v. Mayorkas, (D.D.C. 2022).

Mokkapati v. Mayorkas (Mokkapati v. Mayorkas) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Norton v. Southern Utah Wilderness Alliance
542 U.S. 55 (Supreme Court, 2004)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mashpee Wampanoag Tribal Council, Inc. v. Norton
336 F.3d 1094 (D.C. Circuit, 2003)
Trudeau v. Federal Trade Commission
456 F.3d 178 (D.C. Circuit, 2006)
Islamic American Relief Agency v. Gonzales
477 F.3d 728 (D.C. Circuit, 2007)
In Re Core Communications, Inc.
531 F.3d 849 (D.C. Circuit, 2008)
In Re Barr Laboratories, Inc.
930 F.2d 72 (D.C. Circuit, 1991)
Roger Rudder v. Shannon Williams
666 F.3d 790 (D.C. Circuit, 2012)
Wood v. Moss
134 S. Ct. 2056 (Supreme Court, 2014)
Joseph Arpaio v. Barack Obama
797 F.3d 11 (D.C. Circuit, 2015)
American Hospital Association v. Sylvia Burwell
812 F.3d 183 (D.C. Circuit, 2016)
Skalka v. Johnson
246 F. Supp. 3d 147 (District of Columbia, 2017)
Mirror Lake Village, LLC v. Chad F. Wolf
971 F.3d 373 (D.C. Circuit, 2020)
Joshua Atchley v. Astrazeneca UK Limited
22 F.4th 204 (D.C. Circuit, 2022)